Cargando…

Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance

SIMPLE SUMMARY: Many patients with the aggressive cancer diffuse large B-cell lymphoma (DLBCL) still respond poorly to treatment and suffer from relapsed or refractory disease. The identification of gene mutations that are responsible for the outgrowth of the relapsed tumor is crucial to understand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berendsen, Madeleine R., Stevens, Wendy B. C., van den Brand, Michiel, van Krieken, J. Han, Scheijen, Blanca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/ https://www.ncbi.nlm.nih.gov/pubmed/33260693 http://dx.doi.org/10.3390/cancers12123553

Ejemplares similares

Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma
por: Berendsen, Madeleine R., et al.
Publicado: (2023)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
por: van Bladel, Diede A. G., et al.
Publicado: (2022)

Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
por: Schreuder, Max I., et al.
Publicado: (2017)

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma
por: Nijland, Marcel, et al.
Publicado: (2018)

Artificial intelligence to detect MYC translocation in slides of diffuse large B-cell lymphoma
por: Swiderska-Chadaj, Zaneta, et al.
Publicado: (2020)

How I manage patients with relapsed/refractory diffuse large B cell lymphoma
por: Gisselbrecht, Christian, et al.
Publicado: (2018)

IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma
por: Elfrink, Suraya, et al.
Publicado: (2022)

Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
por: van Bladel, Diede A. G., et al.
Publicado: (2021)

Relapse in stage I(E) diffuse large B‐cell lymphoma
por: Nijland, Marcel, et al.
Publicado: (2017)

Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
por: van Bladel, Diede A. G., et al.
Publicado: (2021)

Management of relapsed-refractory diffuse large B cell lymphoma
por: Raut, Lalit S., et al.
Publicado: (2014)

Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma
por: van Bladel, Diede A. G., et al.
Publicado: (2023)

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Harris, Leonard Jeff, et al.
Publicado: (2020)

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Sehn, Laurie H., et al.
Publicado: (2020)

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021)

Neurolymphomatosis as a manifestation of relapsed diffuse large B‐cell lymphoma
por: Okamura‐Shiki, Ikue, et al.
Publicado: (2022)

Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma
por: Isaev, Keren, et al.
Publicado: (2020)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma
por: Matsuo, Toshihiko, et al.
Publicado: (2018)

Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass
por: Öneç, Birgül, et al.
Publicado: (2016)

Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
por: Wu, Shaohua, et al.
Publicado: (2017)

A diffuse large B cell lymphoma emerging with breast cancer relapse
por: Karismaz, Abdulkadir, et al.
Publicado: (2018)

Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
por: Wang, Shu-Bei, et al.
Publicado: (2019)

Cytomegalovirus lymphadenitis mimicking a relapsed diffuse large B‐cell lymphoma
por: Delaye, Matthieu, et al.
Publicado: (2022)

The clinical challenge of relapsed diffuse large B-cell lymphoma with disseminated infection
por: Goh, Suek Chern, et al.
Publicado: (2023)

Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies
por: Scheijen, Blanca
Publicado: (2019)

Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma
por: Galaznik, Aaron, et al.
Publicado: (2018)

Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses
por: Broséus, Julien, et al.
Publicado: (2016)

A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma
por: van den Brand, Michiel, et al.
Publicado: (2015)

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
por: Vacirca, Jeffrey L., et al.
Publicado: (2013)

MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma
por: Pillar, Nir, et al.
Publicado: (2017)

CNS relapse of diffuse large B cell Lymphoma A single centre experience
por: Nazir, Adil, et al.
Publicado: (2017)

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia
por: Balasubramanian, Priyavadhana, et al.
Publicado: (2019)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma
por: Kong, Xiaoshuang, et al.
Publicado: (2023)

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
por: Desai, Sanjal H., et al.
Publicado: (2022)

Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
por: Bojanini, Leyla, et al.
Publicado: (2023)

New Insights into Diffuse Large B-Cell Lymphoma Pathobiology
por: Solimando, Antonio Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h00199740gu95sh001pkmi4m1h